Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility.
about
Therapeutic Approach to Adult Fibrotic Lung DiseasesEpidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative ReviewProton pump inhibitors alter the composition of the gut microbiotaClinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors.Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study.Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.Recurrent Clostridium difficile infection and the microbiome.Fecal microbiota analysis: an overview of sample collection methods and sequencing strategies.A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors.Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based StudyGeriatric Respondents and Non-Respondents to Probiotic Intervention Can be Differentiated by Inherent Gut Microbiome Composition.Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial.Taxa of the Nasal Microbiome Are Associated with Influenza-Specific IgA Response to Live Attenuated Influenza Vaccine.Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoeaNational age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals.Fulfilling the Promise of Microbiomics to Revolutionize MedicineThe Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant DiseaseRanitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study.Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.A longitudinal study of the diabetic skin and wound microbiome.Gut microbiota impact on stroke outcome: Fad or fact?Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review.Gut microbiome interactions with drug metabolism, efficacy, and toxicity.Consensus report: faecal microbiota transfer - clinical applications and procedures.Antibiotic-Associated Apoptotic Enterocolitis in the Absence of a Defined Pathogen: The Role of Intestinal Microbiota Depletion.Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract.Dysbiosis, Spleen Qi, Phlegm, and Complex DifficultiesControl of Clostridium difficile Infection by Defined Microbial Communities.Erratum to: Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility.Sleeping with the enemy: Clostridium difficile infection in the intensive care unit.Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.Editorial: further evidence that proton pump inhibitors may impact on the gut microbiota.Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications.Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.
P2860
Q26741569-5B4E326C-3EB9-4984-9D2F-B691A0917B0FQ28073805-47D5559D-7F4D-466E-BFE0-140D3F40DB65Q28603378-35CD0D38-C96C-41C4-9B5F-F6D821F24A8FQ31157434-7314EADC-8E18-4B1F-B72D-44724AF8E044Q33666086-08285611-6BC8-45EF-8F69-D325DA41932BQ34503739-F085CA66-5CAE-439C-AC14-7E784ECAED94Q35685694-3E16CF94-1324-402D-A559-445794C1D434Q35766366-51342356-AA33-4F74-B342-442B8B1501EFQ35938718-DA600576-E1D8-4A46-AEB5-E244281B8235Q35956651-8877D1A4-118E-4BCC-85F6-F2856CD481D7Q35999704-AF238AB1-47F0-4252-A48A-3FEEA1ED663AQ36033672-5F7F7CB4-F972-4F7C-9708-29229A94022CQ36096116-D5B13230-614F-4C23-AE08-82A4BC202EA4Q36137294-15BDA8FE-B913-40CD-B9F3-455004445F63Q36140398-156D92BA-FF05-4088-9CB4-0CDF6CAED7CBQ36195428-047158C6-05F6-43E8-9D22-2C1DD54FB8E7Q36733786-2EFC35B1-1B86-4894-98CC-E2575D6C990EQ37147989-DBB4D58D-02BA-4EA7-9CD2-422F9E978E53Q37222105-354EF58E-2B3E-41FF-B218-54AC898B9BFEQ37381752-C7C8748B-0E3D-49FC-A889-25806B4136FAQ37395942-2C13DF98-0C48-45A1-A431-2306BB1CD351Q37709906-7B21E5A0-F040-4D4C-8592-B23B79F79E83Q38663267-089AC31E-6B03-4A52-B031-63A798A93EF4Q38761518-818C8AE3-5712-40CB-8595-756EF73A0F7BQ38865456-3A8F3206-C13D-4E74-815B-6E705FB061ADQ38880576-BCAB5325-089E-43CC-81E7-72CE5728C12AQ38919138-31A5B973-9D11-4980-9438-48429AFB7B53Q38945423-6B0F257C-CE59-42A7-AA88-C39B5FB9934BQ39021811-194E076C-5B6F-4B5A-97E8-C43C7CFC8677Q39606031-D1235070-F1BC-4DC5-BD6D-BC164943EAB6Q39746808-36FCDBD3-3E78-4438-86DD-A00D0532F40EQ41027606-8229C466-FD02-4EB7-82C4-B9425FF6A1A4Q41932327-59B3DE75-E4D8-4B9D-893F-27F15D07668BQ42585333-B6328F2F-EA5E-42F9-A611-F6B147B260E5Q42654359-BF2C11C5-D012-47DC-841A-7B15189A7769Q42695192-5DCA804A-7A2A-4D13-B31D-693A13D2D244Q46564600-93BD09FB-3B10-4C37-BBA5-F55D9398B220Q47095023-8CFFC290-CABE-4BEE-B9E0-3AB10ACD361FQ47283908-F9C5352A-ADC2-4514-8D90-B6074C18D519Q47742865-34557E14-DEE0-4120-93E0-CBD60F750871
P2860
Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prolonged use of a proton pump ...... dium difficile susceptibility.
@ast
Prolonged use of a proton pump ...... dium difficile susceptibility.
@en
Prolonged use of a proton pump ...... dium difficile susceptibility.
@nl
type
label
Prolonged use of a proton pump ...... dium difficile susceptibility.
@ast
Prolonged use of a proton pump ...... dium difficile susceptibility.
@en
Prolonged use of a proton pump ...... dium difficile susceptibility.
@nl
prefLabel
Prolonged use of a proton pump ...... dium difficile susceptibility.
@ast
Prolonged use of a proton pump ...... dium difficile susceptibility.
@en
Prolonged use of a proton pump ...... dium difficile susceptibility.
@nl
P2093
P2860
P356
P1433
P1476
Prolonged use of a proton pump ...... dium difficile susceptibility.
@en
P2093
Charlie T Seto
John K DiBaise
Nicholas Chia
Patricio Jeraldo
Robert Orenstein
P2860
P2888
P356
10.1186/2049-2618-2-42
P577
2014-11-25T00:00:00Z
P5875
P6179
1049713854